Valsartan is an orally active non-peptide angiotensin receptor antagonist, an effective and
well-tolerated anti-hypertensive drug. Besides its antihypertensive action, it has clinical …

Background The interference can be a significant source of laboratory errors with the
potential to cause immunoassay results to drift. Therefore, we evaluated the interference in …

The primary objective of this main study is to develop and assess the sustained-release
matrix tablets containing Valsartan, an angiotensin II receptor type 1 antagonist. The powder …

Cardiovascular breakdown is one among the main sources of morbidity and mortality
around the world. FDA has approved Sacubitril/valsartan, an angiotensin receptor-neprilysin …

Background: Valsartan, an angiotensin blocker, is often combined with amlodipine (a
calcium channel antagonist) in the current treatment of hypertension. There is a generic …

تعتبر الأذيّة الكلويّة الحادّة المحدثة بالسيسبلاتين من المضاعفات الخطيرة الناتجة عن العلاج
الكيميائي للأورام بالسيسبلاتين، حيث يعدّ السيسبلاتين من أكثر العوامل الكيميائيّة استخداماً …‎

Актуальность темы. Хроническая сердечная недостаточность (ХСН) и сахарный
диабет (СД) 2 типа нередко сосуществуют у одного и того же больного, имеют целый …

Valsartan is used as a hypertension therapy that reduces blood pressure by inhibiting the
activity of angiotensin II only at the AT1 receptor, hence it is also called ARB (angiotensin …